Clinical Edge Journal Scan

Dietary thiamine intake reduces risk for migraine


 

Key clinical point: Participants, especially women and those aged 50-85 years, who had a high intake of dietary thiamine were less likely to develop severe headache or migraine.

Major finding: Dietary thiamine intake was associated with a reduced risk for migraine or headache (adjusted odds ratio [aOR] 0.93; P = .046), particularly among women (aOR 0.90; P = .022) and those aged 50-85 years (aOR 0.86; P = .023).

Study details: Findings are from a cross-sectional study including 13,439 American adults, of which 2745 experienced migraine or severe headache in the past 3 months.

Disclosures: This study did not declare any source of funding. The authors declared no conflicts of interest.

Source: Li D et al. Dietary intake of thiamine and riboflavin in relation to severe headache or migraine: A cross-sectional survey. Headache . 2022 (Sep 1). Doi: 10.1111/head.14384

Recommended Reading

Possible link between dietary niacin intake and migraine prevalence
Migraine ICYMI
Meta-analysis demonstrates link between migraine and cognitive impairment
Migraine ICYMI
Erenumab, an effective option for treatment-resistant chronic migraine
Migraine ICYMI
Insights on symptoms and burden of migraine
Migraine ICYMI
CGRP antagonists effectively reduce monthly headache days in chronic migraine with medication overuse headache
Migraine ICYMI
Commentary: Better Migraine Outcomes Measures, September 2022
Migraine ICYMI
Lasmiditan effective for acute treatment of perimenstrual migraine
Migraine ICYMI
Migraine: Combination therapy more effective than either of manual therapies
Migraine ICYMI
Ubrogepant more beneficial in migraine patients with mild vs moderate or severe pain
Migraine ICYMI
Fremanezumab improves disability outcomes in patients with episodic and chronic migraine
Migraine ICYMI